75 related articles for article (PubMed ID: 3592927)
21. [Neurotropic activity of phenylpyrrolidones-2].
Khaunina RA
Biull Eksp Biol Med; 1978 Mar; 85(3):301-4. PubMed ID: 667325
[TBL] [Abstract][Full Text] [Related]
22. General pharmacological properties of a low molecular weight heparin in rodents.
Fantuz M; Bertoli D
Arzneimittelforschung; 1986 Sep; 36(9):1366-8. PubMed ID: 3790187
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, chemical and pharmacological properties of some N-aminoalkyl derivatives of 3,4-pyridinedicarboxamides.
Sĺadowska H; Potoczek ; Sieklucka-Dziuba M; Semczuk A; Kleinrok Z
Farmaco; 1995 Nov; 50(11):761-8. PubMed ID: 8593173
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary pharmacological evaluation of new imidazolidinone-2, ethylenediamine and imidazoline derivatives].
Jagiełło-Wójtowicz E; Zebrowska-Lupina I; Wielosz M; Stelmasiak M; Szurska G; Porowska A; Kleinrok Z
Acta Pol Pharm; 1984; 41(4):495-504. PubMed ID: 6532135
[No Abstract] [Full Text] [Related]
25. Pharmacological properties of alpha-phenyltetrahydrofuranone-2-gamma-carboxylic acid and its derivatives.
Barczynska J
Arch Immunol Ther Exp (Warsz); 1973; 21(2):309-27. PubMed ID: 4738976
[No Abstract] [Full Text] [Related]
26. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models.
Bertollo CM; Oliveira AC; Rocha LT; Costa KA; Nascimento EB; Coelho MM
Eur J Pharmacol; 2006 Oct; 547(1-3):184-91. PubMed ID: 16962092
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary pharmacologic evaluation of new derivatives of 2-anilinoimidazoline and aminoimidazoline].
Jagiełło-Wójtowicz E; Wielosz M; Sieklucka-Dziuba M; Stelmasiak M; Kleinrok Z
Acta Pol Pharm; 1988; 45(4):351-8. PubMed ID: 3245472
[No Abstract] [Full Text] [Related]
28. Endorphins in traumatic spinal injury. Pathophysiologic studies and clinical implications.
Faden AI; Holaday JW
Mod Probl Pharmacopsychiatry; 1981; 17():158-74. PubMed ID: 6276721
[No Abstract] [Full Text] [Related]
29. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
30. The effects of chlorpyrifos on blood pressure and temperature regulation in spontaneously hypertensive rats.
Smith EG; Gordon CJ
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):503-11. PubMed ID: 15910416
[TBL] [Abstract][Full Text] [Related]
31. Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats.
Ilbäck NG; Siller M; Stålhandske T
Lab Anim; 2008 Apr; 42(2):149-60. PubMed ID: 18435873
[TBL] [Abstract][Full Text] [Related]
32. [Effect of emotionality, exploratory activity and pain sensitivity on manifestation of agonistic behavior in the mouse].
Kudriavtseva NN; Sitnikov AP
Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(4):686-91. PubMed ID: 3765835
[TBL] [Abstract][Full Text] [Related]
33. Microinjection of prostaglandin E2 and muscimol into the preoptic area in conscious rats: comparison of effects on plasma adrenocorticotrophic hormone (ACTH), body temperature, locomotor activity, and cardiovascular function.
Zaretsky DV; Hunt JL; Zaretskaia MV; DiMicco JA
Neurosci Lett; 2006 Apr; 397(3):291-6. PubMed ID: 16406311
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography.
Vaupel DB; Tella SR; Huso DL; Wagner VO; Mukhin AG; Chefer SI; Horti AG; London ED; Koren AO; Kimes AS
J Pharmacol Exp Ther; 2005 Jan; 312(1):355-65. PubMed ID: 15331657
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic properties of the dilactone of bis-(beta-hydroxypropyl)-malonic acid.
Pelczarska A; Prastowski W
Arch Immunol Ther Exp (Warsz); 1967; 15(6):912-9. PubMed ID: 5586112
[No Abstract] [Full Text] [Related]
36. [Effect of aminazin on growth and development of young rats].
Rozanova VD
Biull Eksp Biol Med; 1972 Sep; 73(9):60-1. PubMed ID: 4638366
[No Abstract] [Full Text] [Related]
37. Synthesis and pharmacological study of some derivatives of pyrazolo[4,3-c]pyrido[3,2-c]-1,2-thiazine-5,5-dioxide, a novel heterocyclic ring system.
Malinka W; Sieklucka-Dziuba M; Rajtar-Cynke G; Gasior M; Kleinrok Z
Farmaco; 1995 Jan; 50(1):29-35. PubMed ID: 7702718
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics and effects of xylazine (Rompun) in dogs].
Rector E; Otto K; Kietzmann M; Nolte I; Lehmacher W
Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):18-22. PubMed ID: 8593154
[TBL] [Abstract][Full Text] [Related]
39. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
Hardman HF; Domino EF; Seevers MH
Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
[No Abstract] [Full Text] [Related]
40. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]